- Home
- About Roche
- Products
- Corporate Responsibility
- Research & Development
- Media
- Investors
- Careers
Facts and Figures in R&D
Roche spends more than 8 billion Swiss francs on research and development and employs over 7000 people in R&D.
A unique R&D network model and strong alliances with companies, universities and research institutions worldwide give our scientists broadest access to innovation.
| 2008 | 2007 | % change CHF | % change LC | 2008 % of sales | 2007 % of sales | |
|---|---|---|---|---|---|---|
| Group | 8,845 | 8,385 | + 5 | + 13 | 19.4 | 18.2 |
| 2008 | % change CHF | % change LC | % of sales | |
|---|---|---|---|---|
| Pharmaceuticals | 7,904 | 4 | 11 | 22.0 |
| Diagnostics | 941 | 20 | 26 | 9.7 |
Roche has Pharma Research centers around the world with more than 2500 scientists passionate about discovering medicines to meet the unmet medical needs of patients.
In Pharma Development about 4,000 scientists and physicians around the world design and conduct preclinical and clinical trials to transform promising compounds into clinically differentiated medicines for patients.
The Research and Development sites focus on specific Disease Biology Areas or on strategic areas of research technologies and/or specific areas in preclinical or clinical development. They are:
| Location | Focus area |
|---|---|
| Basel, Switzerland (R&D) | Metabolics and Central Nervous System |
| Kulmbach Germany (R) | RNA-based Therapeutics |
| Madison (WI), USA (R) | RNA interference |
| Nutley (NJ), USA (R&D) | Oncology and Metabolics |
| Palo Alto (CA), USA (R) | Inflammation and Virology |
| Penzberg, Germany (R) | Protein Therapeutics |
| Schlieren, Switzerland (R) | Antibody engineering |
| Shanghai, China (R&D) | Research and Clinical Development |
| Sydney, Australia (D) | Clinical Development Operations |
| Toronto, Canada (R) | Antibody Therapeutics |
| Welwyn, United Kingdom (D) | Pharmaceutical Development |